INSPECS Group plc Stock
Stocks
SPEC
GB00BK6JPP03
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
London S.E.
03:35:10 30/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 90.00 GBX | 0.00% |
|
0.00% | +25.87% |
| 11/09 | EARNINGS AND TRADING: Physiomics celebrates new contract wins | AN |
| 10/09 | INSPECS Group plc Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 131M 117M 108M 98.26M 184M 12.46B 186M 1.3B 517M 6.52B 491M 480M 20.69B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 86.72M 77.8M 71.93M 65.14M 122M 8.26B 123M 860M 343M 4.32B 325M 319M 13.72B | EV / Sales 2026 * |
0.32x | EV / Sales 2027 * | 0.31x |
| Free-Float |
10.75% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| SPEC | Delayed | |
Deutsche Boerse AG
| 4GV | Delayed |
| 04/03 | Form 8.3 - Inspecs Group Plc | AQ |
| 11/02 | Form 8.3 - Inspecs Group Plc | AQ |
| 09/02 | Form 8.3 - [INSPECS GROUP PLC - 06 02 2026] - (CGAML) | AQ |
| 28/01 | Form 8.3 - Inspecs Group Plc | AQ |
| 07/01 | Form 8.3 - Inspecs Group Plc | AQ |
| Current month | -3.74% | ||
| 1 month | -3.74% | ||
| 3 months | -6.25% | ||
| 6 months | +7.78% | ||
| Current year | +25.87% |
| 1 week | 87 |  | 93 |
| 1 month | 87 | | 93 |
| Current year | 60 | | 105 |
| 1 year | 60 | | 105 |
| 3 years | 37 | | 105 |
| 5 years | 37 | | 420 |
| 10 years | 37 | | 420 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Peck
CEO | Chief Executive Officer | 62 | 01/12/2022 |
Christopher Kay
DFI | Director of Finance/CFO | 63 | - |
Angela Eman
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Peck
BRD | Director/Board Member | 62 | 10/01/2020 |
Angela Farrugia
BRD | Director/Board Member | 61 | 12/05/2020 |
Luke Johnson
BRD | Director/Board Member | 64 | 19/05/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/6/25 | Free | Chief Executive Officer | 250,000 | 0.2459% | ||
| 4/6/25 | Free | Chief Executive Officer | 150,000 | 0.1475% | ||
| 8/11/22 | Buy | Chief Executive Officer | 833,333 | 0.8196% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +45.16% | +16.88% | 131M | |
| +1.32% | +1.40% | -16.46% | +11.77% | 178B | |
| +2.65% | +1.53% | -15.64% | +18.74% | 117B | |
| +2.05% | +0.02% | +5.31% | +38.07% | 116B | |
| +0.28% | +0.59% | -44.02% | +5.89% | 91.03B | |
| +0.94% | -3.15% | -1.61% | +76.81% | 61.89B | |
| -0.32% | -0.66% | +10.51% | +81.65% | 55.85B | |
| +0.55% | -2.12% | +8.08% | -21.87% | 53.16B | |
| +1.66% | +0.77% | -9.01% | +44.08% | 44.35B | |
| +1.94% | +1.59% | -1.11% | -6.97% | 33.59B | |
| Average | +1.11% | +0.85% | -1.88% | +26.51% | 75.02B | |
| Weighted average by Cap. | +1.37% | +1.25% | -10.20% | +25.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 267M 240M 222M 201M 375M 25.45B 380M 2.65B 1.06B 13.32B 1B 981M 42.27B | 277M 248M 230M 208M 388M 26.35B 393M 2.74B 1.09B 13.79B 1.04B 1.02B 43.78B |
| Net income | - | - |
| Net Debt | -44.08M -39.54M -36.56M -33.11M -61.86M -4.2B -62.61M -437M -174M -2.2B -165M -162M -6.97B | -45.44M -40.77M -37.69M -34.14M -63.77M -4.33B -64.55M -451M -179M -2.26B -171M -167M -7.19B |
Employees
1,656
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | GBX 90.00 | 0.00% | 20,659 |
| 28/10/26 | GBX 90.00 | 0.00% | 5,668 |
| 27/10/26 | GBX 90.00 | 0.00% | 0 |
| 26/10/26 | GBX 90.00 | 0.00% | 0 |
| 23/10/26 | GBX 90.00 | 0.00% | 6,928 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.198USD
Average target price
0.8180USD
Spread / Average Target
-31.72%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SPEC Stock
Select your edition
All financial news and data tailored to specific country editions
